These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
363 related articles for article (PubMed ID: 25365085)
41. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients. Keenan RT; Swearingen CJ; Yazici Y Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813 [TBL] [Abstract][Full Text] [Related]
42. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
43. 14-3-3η: a novel biomarker platform for rheumatoid arthritis. Maksymowych WP; Marotta A Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-35-9. PubMed ID: 25365087 [TBL] [Abstract][Full Text] [Related]
44. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE; J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764 [TBL] [Abstract][Full Text] [Related]
45. Seropositivity of Rheumatoid Arthritis Specific Tests in a Patient With Nephrotic Syndrome: Successful Treatment With Rituximab. Mirzaei A; Ataeipoor Y; Asgari M; Zabihiyeganeh M Iran J Kidney Dis; 2017 Nov; 11(6):467-468. PubMed ID: 29190608 [TBL] [Abstract][Full Text] [Related]
46. The value of rheumatoid factor and anti-citrullinated protein antibodies as predictors of response to infliximab in rheumatoid arthritis: an exploratory study. Klaasen R; Cantaert T; Wijbrandts CA; Teitsma C; Gerlag DM; Out TA; de Nooijer MJ; Baeten D; Tak PP Rheumatology (Oxford); 2011 Aug; 50(8):1487-93. PubMed ID: 21454308 [TBL] [Abstract][Full Text] [Related]
47. [Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL)]. Karateev DE; Luchikhina EL; Tiurina LN; Chemeris NA; Pogozheva EIu; Lukina GV; Potanin AIu; Shostak NA; Kogan KM; Demidova NV; Kasumova KA; Pozdniakova ES; Fedorenko EV; Aleksandrova EN; Novikov AA; Smirnov AV; Nasonov EL Ter Arkh; 2008; 80(5):8-13. PubMed ID: 18590106 [TBL] [Abstract][Full Text] [Related]
48. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281 [TBL] [Abstract][Full Text] [Related]
49. Outcome of rheumatoid arthritis following adjunct statin therapy. Das S; Mohanty M; Padhan P Indian J Pharmacol; 2015; 47(6):605-9. PubMed ID: 26729950 [TBL] [Abstract][Full Text] [Related]
50. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Berglin E; Johansson T; Sundin U; Jidell E; Wadell G; Hallmans G; Rantapää-Dahlqvist S Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994 [TBL] [Abstract][Full Text] [Related]
51. Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis. Fisher BA; Plant D; Brode M; van Vollenhoven RF; Mathsson L; Symmons D; Lundberg K; Rönnelid J; Venables PJ Ann Rheum Dis; 2011 Jun; 70(6):1095-8. PubMed ID: 21367760 [TBL] [Abstract][Full Text] [Related]
52. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Hammer HB; Ødegård S; Syversen SW; Landewé R; van der Heijde D; Uhlig T; Mowinckel P; Kvien TK Ann Rheum Dis; 2010 Jan; 69(1):150-4. PubMed ID: 19095696 [TBL] [Abstract][Full Text] [Related]
53. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954 [TBL] [Abstract][Full Text] [Related]
54. Can RAPID3, an index without formal joint counts or laboratory tests, serve to guide rheumatologists in tight control of rheumatoid arthritis in usual clinical care? Pincus T Bull NYU Hosp Jt Dis; 2009; 67(3):254-66. PubMed ID: 19852747 [TBL] [Abstract][Full Text] [Related]
55. Longitudinal analysis of citrullinated protein/peptide antibodies (anti-CP) during 5 year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Rönnelid J; Wick MC; Lampa J; Lindblad S; Nordmark B; Klareskog L; van Vollenhoven RF Ann Rheum Dis; 2005 Dec; 64(12):1744-9. PubMed ID: 15843452 [TBL] [Abstract][Full Text] [Related]
56. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
57. Prevalence and predictive value of anti-cyclic citrullinated protein antibodies for future development of rheumatoid arthritis in early undifferentiated arthritis. Emad Y; Shehata M; Ragab Y; Saad A; Hamza H; Abou-Zeid A Mod Rheumatol; 2010 Aug; 20(4):358-65. PubMed ID: 20364358 [TBL] [Abstract][Full Text] [Related]
58. Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System. Martin L; Steber WA; Lupton TL; Mahler M; Fitch CM; McMillan JD; Schmidt DR; Fritzler MJ J Rheumatol; 2015 May; 42(5):771-7. PubMed ID: 25641884 [TBL] [Abstract][Full Text] [Related]
59. Rheumatoid arthritis patients have elevated antibodies to cross-reactive and non cross-reactive antigens from Proteus microbes. Rashid T; Jayakumar KS; Binder A; Ellis S; Cunningham P; Ebringer A Clin Exp Rheumatol; 2007; 25(2):259-67. PubMed ID: 17543151 [TBL] [Abstract][Full Text] [Related]
60. Disability measured by the modified health assessment questionnaire in early rheumatoid arthritis: prognostic factors after two years of follow-up. Graell E; Vazquez I; Larrosa M; Rodríguez-Cros JR; Hernández MV; Gratacós J; Gómez A; Cañete JD; Gómez-Puerta JA; Sanmartí R Clin Exp Rheumatol; 2009; 27(2):284-91. PubMed ID: 19473570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]